Patents
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
05/1999
05/06/1999WO1999021568A1 Metal/thiol biocides
05/06/1999WO1999021567A1 Pharmaceutical compositions for oral administration of molecular iodine
05/06/1999WO1999021547A1 Stable solution of zinc and bicarbonate ions
05/06/1999WO1999008729A9 Loading and release of water-insoluble drugs
05/06/1999WO1999008691A3 Use of locally delivered metal ions for treatment of periodontal disease
05/06/1999EP0913358A1 Process for the preparation of periodates
05/06/1999EP0913155A2 Pharmaceutical formulation for treating liver disorders
05/06/1999EP0912442A1 Use of silica as agent for controlling the degradation of bicarbonate, resulting mixture and its application
05/06/1999EP0912198A1 Immunoliposomes that optimize internalization into target cells
05/06/1999EP0912196A1 Use of a thexaphyrin in the preparation of a medicament for use with a chemotherapeutic agent in cancer chemosensitization
05/06/1999EP0912187A2 Compositions and methods for the prevention and treatment of atherosclerosis and reperfusion injury with magnesium salts
05/06/1999EP0912095A1 Phosphate composition and its utilization
05/06/1999EP0677990B1 Compositions and uses thereof
05/06/1999DE19812652A1 Use of L-citrulline
05/06/1999DE19748290A1 Solution for peritoneal dialysis or infusion comprising heat sterilized solutions one containing calcium and glucose and the other bicarbonate
05/06/1999CA2658884A1 Metal/thiol biocides
05/05/1999CN1215610A Antipyretic and antitoxic particles and preparing method thereof
05/05/1999CN1215606A Calcium product and raw material thereof, and process of producing thereof
05/05/1999CN1215605A 'Shilongqingxue' Instant particle for treating hematencephalon
05/04/1999US5900429 Treating breast cancer in mammals by administering taxol or cisplatin to reduce tumor or cancer, then administering 2-methoxycarbonylaminobenzimidazole or pharmaceutical addition salts; anticarcinogenic/antitumor agents
05/04/1999US5900424 Omeprazole magnesium salt form
05/04/1999US5900410 Monotherapy of peptic ulcers and gastritis
05/04/1999US5900360 Screening protein stabilizing agents (not congo red) by incubating cell containing conformationally defective protein, determining effective concentration to improve phenotype; treatment of cystic fibrosis, scrapie
05/04/1999US5900257 Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists
05/04/1999US5900255 Material for prevention and treatment of osteoporosis
05/04/1999CA2149835C Process for the purification of nitric oxide
05/04/1999CA2108008C Antimicrobial compositions useful for medical applications
05/04/1999CA1340527C Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities
04/1999
04/29/1999WO1999020287A1 The use of an aqueous solution in the preparation of a medicament for use in the treatment of live animals
04/29/1999WO1999020286A1 A composition for the treatment of legionella pneumophila and a method for such treatment
04/29/1999WO1999020264A1 Formulations and methods for reducing toxicity of antineoplastic agents
04/29/1999WO1999020251A1 Use of inhaled no as anti-inflammatory agent
04/29/1999WO1999020249A1 Solution for peritoneal dialysis and process for its manufacture
04/29/1999WO1999020237A1 Stomatic composition
04/29/1999WO1999020107A1 Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions
04/29/1999WO1999007401A3 The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases
04/28/1999EP0911031A2 Use of arsenic for preparing a medicament for the treatment of premenstrual syndrome
04/28/1999EP0910960A2 Calcium product and a raw material for the product and processes for their preparation
04/28/1999EP0910460A1 Iodinated matrices for disinfecting biological fluids
04/28/1999EP0910392A2 Oxygen anion radicals and/or therapeutic preparations containing their reaction or breakdown products, and use of such preparations in the treatment of parkinson's disease
04/28/1999EP0910391A1 Nitric oxide inhalation for the prophylaxis and treatment of inflammatory response
04/28/1999EP0910388A1 Pharmaceutical preparation for the treatment of gastritis, reflux oesophagitis, duodenitis, dyspepsia and ulcer disease
04/28/1999EP0910382A1 Treatment of carcinomas using squalamine in combination with other anti-cancer agents
04/28/1999EP0910360A1 Reduction of cardiotoxicity of an antitumor agent using manganese compound
04/28/1999EP0910357A1 Down-regulation of dna repair to enhance sensitivity to p53-mediated suppression
04/28/1999EP0910340A1 Functionalized nanotubes
04/28/1999CN1214926A External-use medicine for curing hyperosteogeny and protrusion of intervertebral disc
04/28/1999CN1214922A Traditional Chinese medicine composition for external use of curing rheumatic arthritis
04/28/1999CN1214919A Oral liquid for anti-cancer
04/27/1999US5898037 Formulations of magnesium compounds for local application and methods of treatment using the same
04/27/1999US5898036 Potentiates the action, reduces the side effects of known compositions used to treat these disorders
04/27/1999US5897891 Consists of a zinc compound, a mono-carboxylic amino acid, and lesser amount of copper compound; pleasant flavor
04/27/1999US5897879 Sustained-release pharmaceutical system for the delivery of antioxidants
04/27/1999US5897854 Deodorizing with water-soluble cyclodextrin and a perfume composition, water; no irritating to sensitive skin areas
04/27/1999CA2129635C Method of ophthalmic drug delivery
04/22/1999WO1999018978A1 Bovine teat dip
04/22/1999WO1999018949A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal
04/22/1999WO1999018798A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
04/22/1999WO1999018797A1 Method and devices for transdermal delivery of lithium
04/22/1999DE19745712A1 New composition for treating sickle cell disease
04/22/1999CA2308489A1 Method and devices for transdermal delivery of lithium
04/22/1999CA2307208A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
04/22/1999CA2306096A1 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal
04/21/1999EP0868172A4 Direct compression carbonyl iron tablet
04/21/1999EP0369000B1 Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities
04/21/1999CN1214257A Chinese medicine for curing gastric cancer and esophagus cancer
04/21/1999CN1214211A Anti-senility cancer-preventing health beverage
04/20/1999US5895787 Treatment of fibromyalgia and related disorders
04/20/1999US5895642 Pseudocatalase activity
04/20/1999CA2192602C Induction of cell differentiation, apoptosis and necrosis of malignant cells such as leukemia using ozone and synergies with known cell differentiation drugs
04/20/1999CA2128230C Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
04/15/1999WO1999017787A2 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
04/15/1999WO1999017782A1 Composition for treatment of diabetes and treatment of diabetes
04/15/1999WO1999017768A1 Treatment of fibromyalgia and related disorders
04/15/1999WO1999017765A1 Use of d-methionine to reduce the toxicity of ototoxic drugs, noise, and radiation
04/15/1999WO1999017762A1 Concentrate for medical solution and use thereof
04/15/1999WO1999017751A1 Controlled release solid dosage forms of lithium carbonate
04/15/1999CA2306273A1 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
04/15/1999CA2305535A1 Controlled release solid dosage forms of lithium carbonate
04/14/1999EP0908169A2 Composition for use as a wound dressing
04/14/1999EP0907366A1 Combination therapy for treatment of erectile dysfunction
04/14/1999CN1213564A Chinese medicinal pills for treating catarct and its prodn. method
04/14/1999CN1213554A Gu'anning ointment for treating hyperosteogeny and its prepn. method
04/14/1999CN1213543A External-use ointment for treating necrosis of head of femur
04/14/1999CN1213514A 天然咖啡因电解质饮料 Natural caffeine electrolyte drinks
04/08/1999WO1999016451A1 Use of vitamin d derivatives to enhance efficacy of cytotoxic agents
04/08/1999WO1999016418A1 Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection
04/08/1999WO1999016309A1 Acidic aqueous chlorite teat dip providing shelf life, sanitizing capacity and tissue protection
04/07/1999EP0906724A1 Pseudoplastic film-forming acidic chlorite composition as teat dip
04/07/1999EP0906105A1 Improvement of implantation rates after in vitro fertilization
04/07/1999EP0906090A1 Method for preventing and treating peripheral neurophathy by administering selegiline
04/07/1999EP0620821B1 Antiviral compositions and method for their use
04/07/1999CN1213355A Bioactive glass compositions and methods of treatment using bioactive glass
04/07/1999CN1213313A Use of thexpahyrin in preparation of medicament for use with a chemotherapeutic agent in cancer chemosensitization
04/07/1999CN1213300A Method for preventing and treating peripheral neurophathy by administering selegiline
04/07/1999CN1212893A Bioactivity compound bone material and preparation method thereof
04/07/1999CN1212886A Pill for treating hepatopathy
04/07/1999CN1042839C Multifunction wine
04/06/1999US5891885 Method for treating migraine
04/06/1999US5891457 Treating menorrhagia with silver nitrate composition